Amneal Pharmaceuticals, Inc. (AMRX) DCF Valuation

Amneal Pharmaceuticals, Inc. (AMRX) DCF Valuation
  • Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • Predeterminadas Para Un Uso Rápido Y Eficiente
  • No Se Necesita Experiencia; Fáciles De Seguir

Amneal Pharmaceuticals, Inc. (AMRX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Regardless of whether you're an investor or an analyst, this (AMRX) DCF Calculator is your go-to resource for accurate valuation. It comes preloaded with real data from Amneal Pharmaceuticals, Inc., allowing you to adjust forecasts and immediately observe the effects.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 1,626.4 1,992.5 2,093.7 2,212.3 2,393.6 2,641.7 2,915.4 3,217.5 3,550.9 3,918.9
Revenue Growth, % 0 22.51 5.08 5.67 8.2 10.36 10.36 10.36 10.36 10.36
EBITDA 155.2 381.0 450.0 150.4 500.8 411.5 454.1 501.2 553.1 610.4
EBITDA, % 9.54 19.12 21.49 6.8 20.92 15.58 15.58 15.58 15.58 15.58
Depreciation 207.2 235.4 233.4 240.2 229.4 296.6 327.4 361.3 398.7 440.0
Depreciation, % 12.74 11.81 11.15 10.86 9.58 11.23 11.23 11.23 11.23 11.23
EBIT -52.0 145.7 216.6 -89.8 271.4 114.8 126.7 139.9 154.4 170.4
EBIT, % -3.2 7.31 10.35 -4.06 11.34 4.35 4.35 4.35 4.35 4.35
Total Cash 151.2 341.4 247.8 26.0 91.5 228.6 252.3 278.4 307.3 339.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 635.9 674.2 662.6 741.8 613.7
Account Receivables, % 39.1 33.84 31.65 33.53 25.64
Inventories 381.1 490.6 489.4 530.7 581.4 632.5 698.0 770.3 850.2 938.3
Inventories, % 23.43 24.62 23.37 23.99 24.29 23.94 23.94 23.94 23.94 23.94
Accounts Payable 103.0 154.1 132.9 166.8 143.6 179.4 198.0 218.5 241.2 266.1
Accounts Payable, % 6.33 7.74 6.35 7.54 6 6.79 6.79 6.79 6.79 6.79
Capital Expenditure -97.4 -66.2 -52.6 -90.6 -69.2 -99.4 -109.7 -121.1 -133.6 -147.4
Capital Expenditure, % -5.99 -3.32 -2.51 -4.1 -2.89 -3.76 -3.76 -3.76 -3.76 -3.76
Tax Rate, % -108.57 -108.57 -108.57 -108.57 -108.57 -108.57 -108.57 -108.57 -108.57 -108.57
EBITAT -142.6 -279.2 139.3 -92.2 566.0 83.7 92.3 101.9 112.5 124.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -946.7 -206.8 311.7 -29.2 780.4 14.2 173.4 191.4 211.2 233.1
WACC, % 8.44 3.34 6.62 8.44 8.44 7.05 7.05 7.05 7.05 7.05
PV UFCF
SUM PV UFCF 647.2
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 242
Terminal Value 7,940
Present Terminal Value 5,647
Enterprise Value 6,295
Net Debt 2,659
Equity Value 3,636
Diluted Shares Outstanding, MM 176
Equity Value Per Share 20.64

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real AMRX financials.
  • Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Amneal Pharmaceuticals’ valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Customizable Financial Inputs: Adjust essential parameters such as revenue growth, EBITDA %, and capital expenditures tailored for Amneal Pharmaceuticals, Inc. (AMRX).
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics for informed decision-making.
  • High-Precision Accuracy: Utilizes Amneal's actual financial data to deliver realistic valuation results.
  • Simplified Scenario Analysis: Effortlessly evaluate various assumptions and analyze different outcomes.
  • Efficiency Booster: Streamline your valuation process without the hassle of creating complex models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Amneal Pharmaceuticals’ pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for investment decisions.

Why Choose This Calculator for Amneal Pharmaceuticals, Inc. (AMRX)?

  • Accurate Data: Utilize real Amneal financials for trustworthy valuation outcomes.
  • Customizable: Tailor essential parameters like growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the pharmaceutical sector.
  • User-Friendly: An intuitive design and clear instructions make it accessible for all users.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Amneal Pharmaceuticals stock (AMRX).
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Amneal Pharmaceuticals (AMRX).
  • Consultants: Deliver professional valuation insights related to Amneal Pharmaceuticals (AMRX) to clients quickly and accurately.
  • Business Owners: Understand how pharmaceutical companies like Amneal Pharmaceuticals (AMRX) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios involving Amneal Pharmaceuticals (AMRX).

What the Template Contains

  • Historical Data: Includes Amneal Pharmaceuticals’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Amneal Pharmaceuticals’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Amneal Pharmaceuticals’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.